Witega
Organic synthesis in laboratory scale for research and industry
1. Services:
• Synthesis of synthetic organic components, intermediate compounds and target structures of mg to kg quantities on customer order
• Laboratory synthesis of stable isotope-labeled compounds (D, 13C, 15N)
• Reference substances for chemical analytics
2. Bid proposal management:
• After receipt of the customer inquiry, we prepare a binding offer for synthesis on the basis of a literature and patent search that includes the price, delivery time, type of delivery and specification.
• Each inquiry will be treated as strictly confidential. Upon request, a legally confirmed non-disclosure agreement can be entered into on short notice.
• Our quotations are prepared on short notice, within one week at the most.
3. Equipment / analysis:
1. Services:
• Synthesis of synthetic organic components, intermediate compounds and target structures of mg to kg quantities on customer order
• Laboratory synthesis of stable isotope-labeled compounds (D, 13C, 15N)
• Reference substances for chemical analytics
2. Bid proposal management:
• After receipt of the customer inquiry, we prepare a binding offer for synthesis on the basis of a literature and patent search that includes the price, delivery time, type of delivery and specification.
• Each inquiry will be treated as strictly confidential. Upon request, a legally confirmed non-disclosure agreement can be entered into on short notice.
• Our quotations are prepared on short notice, within one week at the most.
3. Equipment / analysis:
| Preparative HPLC Flash chromatography Freeze drying system Hydrogenation apparatus Autoclave technology (up to 300 atm; up to 2 liters) Extraction apparatus (6 liters) |
Analytical HPLC UV spectroscopy NMR (300 and 500 MHz) 1H, 13C, 15N, 31P FT-IR Karl Fischer titration (water determination) Elemetal analysis (C,H,N,S) |
| Tên sản phẩm | Quy cách |
|---|---|
| Cyromazine-13C3 | 20 mg |
| Baquiloprim-D6 | 25 mg |
| Baquiloprim | 50 mg |
| GW 501516 | 100 mg |
| GW 501516-13C4 | 50 mg |
| Trimethoprim-D9 | 50 mg |
| 2’,4’-Formoxylidide-D6 | 50 mg |
| Dichloroisoeverninic acid | 50 mg |
| Dichloroisoeverninic acid-D6 | 50 mg |
| Halofuginone-13C6 hydrobromide | 20 mg |
| Halofuginone hydrobromide | 25 mg |
| Ethopabate-D5 | 100 mg |
| Palmitic acid glycidylester-D5 | 25 mg |
| Stearic acid glycidylester-D5 | 25 mg |
| Descyclopropyldicyclanil | 50 mg |
| Descyclopropyldicyclanil-15N3 | 25 mg |
| Griseofulvin-13CD3 | 25 mg |
| Dicyandiamide-13C2,15N2 | 50 mg |
| Diflubenzuron-13C6 | 25 mg |
| 2-Methyl-4-isothiazolin-3-one hydrochloride | 100 mg |
